Sunshine Sentinel

TALLAHASSEE, Fla.—Attorney General Ashley Moody secured a $102.5 million multistate agreement with the maker of Suboxone. Attorney General Moody, with a coalition of 41 other states’ attorneys general, announced the agreement with Indivior, Inc. over claims the company employed illegal monopoly tactics. Florida will receive more than $3.2 million from the settlement.

Attorney General Ashley Moody said, “Defending a competitive market ensures Floridians are not at the will of a single drug company. This agreement guarantees that states will be able to make sure this company refrains from engaging in monopolistic activities in the future.”

Attorney General Moody and the coalition of state attorneys general filed a complaint against Indivior Inc. alleging that the company used illegal means to switch the Suboxone market from tablets to film while attempting to destroy the market for tablets, in order to preserve its drug monopoly. 

The agreement requires Indivior to pay the states $102.5 million. Indivior is also required to comply with negotiated injunctive terms that include disclosures of the following to the states; all citizen petitions to the FDA; introduction of new products and changes in corporate control. These requirements will help the states ensure that Indivior refrains from engaging in the same kind of conduct alleged in the complaint. 

Florida Attorney General Ashley Moody is joined by the attorneys general of the following states and territories in the legal action: Alabama, Alaska, Arkansas, California, Colorado, District of Columbia, Connecticut, Delaware, Georgia, Hawaii, Idaho, Illinois, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Nebraska, New Hampshire, New Mexico, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, Tennessee, Utah, Vermont, Virginia, Washington, West Virginia and Wisconsin.

To view a copy of the agreement, click here.

Original source can be found here.